BIOSTATISTICS SHARED RESOURCE The Biostatistics Shared Resource (BIOS) provides access for LCCC faculty across the basic, clinical, translational and population science spectrum to an experienced staff and recognized national leaders in statistical modeling and analysis. The Center?s breadth of science requires a broad range of expertise available in BIOS and includes for example: population sciences, psychometric analysis, clinical trial design and analysis, basic experimental science as well as ?big data? ?omics. This range requires a core that can be accessed by virtually all members on the ?front end? for experimental design from small undertakings to large trials. Access is encouraged through a weekly walk in clinic centrally located in the Lineberger atrium where faculty and students at all levels can discuss projects at their inception. The masters and doctoral level full time BIOS SR staff operate this clinic and there is also a traditional appointment system for researchers with defined problems. This team is supported by senior biostatisticians with a wide range of expertise from the School of Public Health?s internationally recognized Biostatistics Department. These leaders also serve on the Protocol Review Committee and the Data and Safety Monitoring Committee. Senior faculty are fully engaged in LCCC research as collaborators and researchers in methods, for example in the Biostatistics PO1 in clinical trials methods development. In addition both staff and faculty encourage the participation of graduate students who have the opportunity to engage faculty and peers in statistical review as part of their own training under the guidance of the senior faculty-level statisticians. This facility is a LCCC exclusive SR and was well used by over 100 faculty in fiscal year 2019. BIOS requests $239,374 which is approximately 20% of the total operating costs for this highly subsidized facility sustained by an annual LCCC contribution of ~$1M BIOS has been a key partner in multiple grants and publications over the prior five years, from Dr Rashid?s analysis of Nobel Laureate Aziz Sancar?s work on circadian timing of DNA repair processes to Dr Tan?s design for Dr Song?s project in caregiver?s management of patient symptoms.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-45
Application #
10089837
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-06-01
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Lianga, Noel; Doré, Carole; Kennedy, Erin K et al. (2018) Cdk1 phosphorylation of Esp1/Separase functions with PP2A and Slk19 to regulate pericentric Cohesin and anaphase onset. PLoS Genet 14:e1007029
Allott, Emma H; Geradts, Joseph; Cohen, Stephanie M et al. (2018) Frequency of breast cancer subtypes among African American women in the AMBER consortium. Breast Cancer Res 20:12
Dhungel, Bal Mukunda; Montgomery, Nathan D; Painschab, Matthew S et al. (2018) 'Discovering' primary effusion lymphoma in Malawi. AIDS 32:2264-2266
Cameron, Jennifer E; Rositch, Anne F; Vielot, Nadja A et al. (2018) Epstein-Barr Virus, High-Risk Human Papillomavirus and Abnormal Cervical Cytology in a Prospective Cohort of African Female Sex Workers. Sex Transm Dis 45:666-672
Lim, Joseph K; Liapakis, Ann Marie; Shiffman, Mitchell L et al. (2018) Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis. Clin Gastroenterol Hepatol 16:1811-1819.e4
Wang, Gary P; Terrault, Norah; Reeves, Jacqueline D et al. (2018) Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection. Sci Rep 8:3199
Phillips, Bonnie; Van Rompay, Koen K A; Rodriguez-Nieves, Jennifer et al. (2018) Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques. J Virol 92:
Takaku, Motoki; Grimm, Sara A; Roberts, John D et al. (2018) GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network. Nat Commun 9:1059
Galanis, Evanthia; Anderson, S Keith; Miller, C Ryan et al. (2018) Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02. Neuro Oncol 20:546-556
Agle, Kimberle; Vincent, Benjamin G; Piper, Clint et al. (2018) Bim regulates the survival and suppressive capability of CD8+ FOXP3+ regulatory T cells during murine GVHD. Blood 132:435-447

Showing the most recent 10 out of 1525 publications